Search PubMed⌕ Search

Biomedical subjects

K Endo

Publications and source records attributed to K Endo.

At least 667 records · Page 37Linked to original sources
PubMed1989

Corrosion and tarnish of dental silver-based alloys in 0.1% Na2S and Ringer's solutions. (Part 1) Electrochemical study.

The corrosion behavior of three silver-based alloys, Ag-Sn-Zn, Ag-In, and Ag-Pd-Cu, were investigated by potentiodynamic anodic polarization analysis and the polarization resistance method in 0.1% Na2S and Ringer's solutions. The corrosion activity of the Ag-Sn-Zn alloy was higher in Ringer's solution than in the 0.1% Na2S solution. In contrast, the corrosion rate of the Ag-Pd-Cu alloy was approximately 500 times higher in the 0.1% Na2S solution than in Ringer's solution. The results show that the generally accepted concept that tarnish is merely a surface discoloration due to the deposition of insoluble products is inadequate. The alloy discolors while being severely attacked in the presence of sulfides. For the Ag-In alloy, the corrosion activity in the 0.1% Na2S solution was as high as in Ringer's solution. These silver-based alloys exhibit different electrochemical activities in different solutions. The test solutions for corrosion tests must be carefully chosen for each alloy system through a screening test to replicate the predominant corrosion reaction proceeding in the oral environment.

Corrosion↗
PubMed1989

In vitro study on the corrosion behavior of three commercial Ag-Pd-Cu-Au alloys in Ringer's and 0.1%Na2S solutions.

The corrosion resistance of three commercial Ag-Pd-Cu-Au alloys was estimated in Ringer's and 0.1% Na2S solutions by electrochemical techniques and surface analyses. In Ringer's solution, the three alloys showed high corrosion resistance and there was no significant difference in the anodic polarization characteristics of the three alloys. In the 0.1% Na2S solution, the Alloy A which had the lowest noble metal content (Au + Pd) exhibited the highest anodic reactivity with the largest amount of corrosion product on the alloy surface. It was determined that the Ag-rich phase of Ag-Pd-Cu-Au alloy was preferentially attacked to form Ag2S corrosion product. The polarization resistance data showed that the corrosion rate for Alloy A in 0.1% Na2S solution was determined to be 500 times higher than that in Ringer's solution. The corrosion rate of the alloy in the freely corroded condition can be estimated quantitatively and precisely by measuring the polarization resistance.

Copper↗
PubMed1989

[Lectin histochemical study on human dental pulp. Special reference to odontoblasts and pulp cells].

The present study investigated some lectin affinities of human dental pulps, especially of odontoblasts and pulp cells. The materials were obtained from clinically intact teeth that were caries-free, attrition and/or abrasion-free. Mucopolysaccharide staining was carried out with applied PAS and alcian blue (AB) (pH 1.0 and 2.5). Lectins used were Con A, WGA, RCA-1, UEA-1, DBA, SBA, MPA, LFA, HPA, PNA, and GS-1, and the avidin-biotin peroxidase complex method was employed. Some specimens were tested for PNA binding after treatment with sialidase. The following results were obtained: 1) On PAS and AB staining, the pulp tissue was very weakly or borderline positive. 2) Lectin binding in odontoblasts was intensely positive with Con A, WGA, RCA-1, MPA, and LFA, but negative or very weakly positive with the other lectins examined. 3) Lectin localization in odontoblasts was localized diffusely throughout the cytoplasm. 4) On PNA staining, odontoblasts were negative, but changed to positive after treatment with sialidase. 5) Odontoblast processes showed negative or borderline staining with all lectins used in this study. 6) The pulp cells were clearly positive with Con A, MPA, LFA, RCA-1, and SBA and especially LFA showed an intense reaction with the pulp cells. 7) WGA affinity for odontoblasts was very strong but that for pulp cells was very weak. 8) Lectin binding in pulp cells was observed mainly in the processes of the cells. From the above results, it is clear that the lectin binding pattern of odontoblasts differs from that of pulp cells. The data suggest that D-mannose, N-acetyl-D-glucosamine, D-galactose, and N-acetyl-D-galactosamine residues are localized in the odontoblasts and sialic acid is localized in the pulp cells.

Dental Pulp↗
PubMed1989

[Clinical trial of 111In-antimyosin antibody imaging: (3) Comparison with 99mTc-pyrophosphate imaging].

Clinical value of 111In-antimyosin monoclonal antibody F ab (AM) was compared with 99mTc-pyrophosphate (PYP) in 13 patients with myocardial infarction and 3 patients with myocarditis. Following PYP injection, PYP imaging was performed 3 hours later. Immediately after PYP imaging, AM was administrated and AM images were obtained 48 hours later. Abnormal accumulation in the infarcted myocardium was observed in 11 patients (85%) on AM images but only in 3 patients (23%) on PYP images. All patients within 8 days after the onset of infarction showed abnormal uptake on both images. Of 5 patients with 1 to 2 weeks after the onset of infarction, abnormal uptake was observed in all of them on AM images but only in one of them on PYP imaging. Furthermore, of 6 patients with more than 2 weeks after the onset, AM imaging showed abnormal uptake in 4 (67%) but PYP imaging did not show abnormal uptake in any of them. Similarly. Of 3 patients with myocarditis, diffuse uptake in the myocardium ws observed in 2 of them on AM images but none of them showed abnormal uptake on PYP images. We conclude that AM imaging is a useful means for identifying not only acute stages but also subacute stages of myocardial necrosis where PYP imaging did not show any abnormality.

Adult↗
PubMed1989

Technetium-99m (V) DMSA uptake in amyloidosis.

Technetium-99m(V) DMSA scintigraphy was performed in two patients with pathologically confirmed amyloidosis associated with plasmacytoma. Significant uptake of the tracer was found in the deposition of amyloid. Technetium-99m(V) DMSA scintigraphy could be useful in determining the appropriate region of biopsy and in forecasting the prognosis of patient with plasmacytoma.

Aged↗
PubMed1989

[Clinical features and treatment of lower intestinal hemorrhage].

We have experienced 471 patients with anal bleeding during the past seven years. The Results are as follows: 1. As for the types of disease, incidence of hemorrhoid, colorectal cancer and ulcerative colitis (UC) was high, while that of small intestinal problems was low. 2. In the cases of remarkable bleeding from the lower intestinal tract, massive or acute progressive bleeding was less frequent than expected. 3. Inflammatory diseases were the main causes of massive bleeding. Bleeding by UC was the major indication for urgent operation. In the cases with acute massive hemorrhage, basic complications were often found and the possibility of the diseases of small intestine and blood vessel disorders also should be considered. 4. At the examination of bleeding patients, it is efficient to explore the lower colon and rectum first by colonoscopy or sigmoidoscopy, for most of the bleeding lesions are found in these portions. 5. As for surgical treatment, most of colorectal cancer patients with hemorrhage are able to be operated with wait- and -see management. For UC patients, complete cure operation is possible even if they have high-dose steroid medication.

Adult↗
PubMed1989

[A case report of thyroid papillary cancer that manifested leukocytosis and hypercalcemia after radiotherapy in bone metastasis].

Bone metastasis from a thyroid papillary cancer of a 59-year-old woman had been successfully treated with radiotherapy (6,000 rad) and iodine-131 (120 mCi). One year later, the patient developed leukocytosis (maximum 143,000/mm3) and hypercalcemia (16.0 mg/dl). A colony stimulating factor (CSF) was detectable in her plasma, and nude mice that had been given metastatic tissues similarly developed leukocytosis and hypercalcemia. Leukocytosis and hypercalcemia seemed to have been caused by the CSF produced in the bone metastasized tissues of this thyroid cancer.

Bone Neoplasms↗
PubMed1989

[Antitumor activity of a new platinum complex (R)-(-)-2-aminomethylpyrrolidine (1,1-cyclobutane dicarboxylato) platinum (II) (DWA2114R) by its serial administration].

Antitumor activity of a newly synthesized platinum complex, DWA2114R, by the serial administration was examined and compared with that of cis-diammine-1,1-cyclobutane dicarboxylato platinum (II) (CBDCA). In mice transplanted s.c. with tumor, the serial i.p. administration resulted in the increases of both maximal tolerated dose (MTD) and growth inhibitory ratio (GIR) of DWA2114R than single administration. Such increases in MTD and GIR were also shown by CBDCA, but the degree of these increases, such as the ratio of MTD or GIR by the serial administration compared to that at the single administration, was higher in DWA2114R than CBDCA. GIR of DWA2114R by the serial administration was higher than that of CBDCA at the doses to induce the same toxicity which was estimated by body weight loss. In addition, in the experiment using ascites tumor-bearing mice, better antitumor activity of DWA2114R was shown by the elongation of survival time. These results indicate that the cumulative toxicity of DWA2114R is lower than that of CBDCA, which causes the therapeutic advantages of DWA2114R in the serial administration.

Animals↗
PubMed1989

[Radioimmunoimaging of malignant melanoma with In-111 labeled monoclonal antibody 96.5 and ZME-0.18].

In-111 labeled mouse antimelanoma monoclonal antibody (MoAb) type 96.5 and ZME-018 were examined in patients with malignant melanoma. These antibodies were supplied by Hybriteck Inc. MoAb was conjugated with DTPA first and then labeled with In-111. Radioimmunolocalization of an In-111-MoAb, type 96.5, was investigated in 23 patients with metastatic malignant melanoma. One of the 23 patients examined twice was found to be without any side effects. Seventeen out of these patients were examined with Ga-67 scintigraphy to evaluate clinical usefulness of radioimmunoimaging. Of a total of 58 metastases which had been diagnosed previously by conventional techniques, 45 were visualized by In-111-96.5 scans for an overall true positive image rate of 77.6%. But the imaging rate by Ga-67 scan was 67.4%. From examining for MoAb, ZME-018, in 15 patients, of a total of 43 metastases, 28 were detected by In-111-ZME-018 scan, with an imaging rate of 65.1%. But the imaging rate in Ga-67 scan was 43.2%. Clinical usefulness was recognized to be effective in radioimmunoimaging with MoAb, 111In-111-96.5 and In-111-ZME-018, for the diagnosis of malignant melanoma.

Antibodies, Monoclonal↗
PubMed1989

Listeriosis in hematological malignancies: report of two cases.

Listeriosis occurred in two patients with hematological malignancies, one with adult T-cell leukemia (ATL) (Case 1) and the other with chronic granulocytic leukemia (CGL) (Case 2). In Case 1, listeriosis was the initial manifestation of ATL, while it occurred in Case 2 after prolonged treatment with an alkylating agent and splenic irradiation. In both cases, depressed cell-mediated immunity was considered to be responsible for the listeriosis. Experience with the present two cases has indicated that listeriosis can be an initial manifestation of ATL, and the combination of an alkylating agent and splenic irradiation may increase the risk of listeriosis in patients with CGL.

Adult↗
PubMed1989

[Clinical trial of 111In-antimyosin antibody imaging: (1). Assessment of tracer kinetics and imaging time].

The human clinical trial of 111In-antimyosin antibody was performed in 20 patients with various cardiac disorders to assess its safety and tracer kinetics and to determine the optimal imaging time. There were no side effects derived from this tracer after its administration. The skin test and the antimurine antibody were both negative in any patient. The radiation dose to the kidney (3.6 rad) and to the whole body (0.36 rad) was acceptable. The half life of the blood clearance was 6.3 hours (fast component) and 25.8 hours (slow component) with the relatively high retention of blood activity at 24 hours (21%) and at 48 hours (11%). The planar images at 24 hours after the tracer administration in 4 patients showed high residual blood-pool activity without delineating significant myocardial uptake, while the images at 48 hours clearly demonstrated the presence or absence of discrete myocardial uptake. However, 2 patients showed significant residual blood-pool activity at 48 hours after the injection which needed 72 hour delayed scan in order to identify the myocardial uptake. In one patient, the single-photon tomography (SPECT) was useful to delineate the myocardial uptake from the residual blood-pool activity at 48 hours after the injection. Although this tracer provides an elegant technique for identifying myocardial necrosis, it needs 48 hours delayed scan and/or SPECT imaging because of relatively slow blood clearance.

Aged↗
PubMed1989

[Clinical trial of 111In-antimyosin antibody imaging: (2). Imaging of myocardial infarction and myocarditis].

A new scintigraphic method to detect myocardial necrosis has been developed using antimyosin monoclonal antibody F ab labeled with indium-111 (111In-antimyosin). We investigated 111In-antimyosin scintigraphy in 35 patients with myocardial infarction, 5 patients with myocarditis and 3 patients with angina pectoris. 111In-antimyosin F ab was administered iv and antimyosin images were recorded by planar and single photon emission computed tomography (SPECT) 48-72 hrs after injection. Planar images showed discrete localization of 111In-antimyosin in 26 of 27 patients within 16 days after the onset of acute myocardial infarction in 14 of whom creatine kinase, glutamic oxaloacetic transaminase and lactic dehydrogenase had already normalized. In addition, positive scans were also obtained in 4 of 8 patients 1 to 9 months after the onset of the disease. Three patients with acute myocarditis (two of whom were biopsy-proven) had positive scans 2 and 4 weeks after the onset of the disease. Although mechanism of persistent positive anti-myosin images in the chronic stage remains to be clarified, 111In-antimyosin scintigraphy holds potential promise as a noninvasive method for the detection of myocardial injury.

Adult↗
PubMed1989

[EEG background activity in patients with dementia of the Alzheimer type--with special reference to analysis by t-statistic significance probability mapping (SPM) in Alzheimer's disease and senile dementia].

EEG power amplitude and power ratio data obtained from 15 (3 men and 12 women) patients with Alzheimer's disease (AD) and 8 (2 men and 6 women) with senile dementia of Alzheimer type (SDAT) were compared with similar data from 40 age- and sex-matched normal controls. Compared with the healthy controls, both patient groups demonstrated increased EEG background slowing, and it indicated more slower in AD than in SDAT. Moreover, both groups showed characteristic findings respectively on EEG topography and t-statistic significance probability mapping (SPM). The differences between AD and their controls indicated high slowing with reductions in alpha 2, beta 1 and beta 2 activity. The SPMs of power ratio in theta and alpha 2 bands showed most prominent significance in the right posterior-temporal region and delta and beta bands did in the frontal region. Severe AD indicated only frontal delta slowing compared to mild AD. The differences between SDAT and their controls indicated only mild slowing in delta and theta bands. The SPM of power amplitude showed occipital slowing, whereas the SPM of power ratio showed the slowing in the frontal region. Judging from both topographic findings, these were considered to denote diffuse slow tendency. In summary, these results presumed that in AD, cortical damages followed by EEG slowing with reductions of alpha 2 and beta bands originated rapidly and thereafter developed subcortical (non-specific area in thalamus) changes with frontal delta activity on SPM. On the other hand, in SDAT, diffuse cortico-subcortical damages with diffuse slowing on EEG topography were caused gradually.

Adult↗
PubMed1988

Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology.

Systematically administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is biotransformed into 1-methyl-4-phenylpyridinium ion (MPP+), which enters dopaminergic neurons via the dopamine uptake system to destroy nigral cells. Either MPP+ is retrogradely transported to the cell body after being taken up at the nerve terminals, or the dopamine uptake sites on the cell body and its dendritic processes are responsible for the toxin directly entering the neuron. Using a 200 microliter osmotic minipump, we administered 4 mg of MPTP HCl directly into the unilateral caudate nucleus, i.e., the dopamine nerve terminal area, of monkeys for 14 days. Persistent hemiparkinsonism began to appear in a week. Each monkey exhibited a flexed posture and hypokinesia of the contralateral limbs and circling toward the MPTP-treated side. These disturbances developed within 3 months and maintained a plateau for 3 months until the day of sacrifice. After treatment with apomorphine, there appeared a striking circling away from the MPTP-treated side. Selective cell loss in the MPTP-treated side of the substantia nigra pars compacta was found along the entire rostrocaudal extent relative to the untreated side. In conclusion, MPP+ uptake only at the dopamine nerve terminals and retrograde axonal transport to the cell body seemed sufficient to destroy nigral dopamine cells in the monkey.

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine↗
PubMed1988

Radiolabeled monoclonal antibody 15 and its fragments for localization and imaging of xenografts of human lung cancer.

Monoclonal antibody (MAb) 15 and its F(ab')2 and Fab fragments were radioiodinated, and their biodistribution and imaging were compared in BALB/c nude mice bearing a xenograft of a human lung cancer (TKB-2). Association constants for 125I-labeled MAb 15 IgG, F(ab')2, and Fab were 1.9 X 10(9), 1.8 X 10(9), and 3.7 X 10(8) M-1, respectively. Immunoreactive fractions ranged from 0.59 to 0.50. Cultured TKB-2 cells expressed 1.1 X 10(4) binding sites/cell for MAb 15 IgG in vitro. The binding of a control antibody and the binding of its fragments to TKB-2 cells were less than 3% of the input doses. The mice with the TKB-2 tumors were given simultaneous injections of 10 microCi of 131I-labeled MAb 15 or its fragments and 10 microCi of 125I-labeled control IgG or its fragments. With MAb 15 IgG, the percentage of the injected dose bound per gram of tissue (ID/g) of the tumor was 3.68% at day 7, when the localization index (LI) was 4.38. At day 2 after MAb 15 F(ab')2 injection, 1.12% of the ID/g was localized in the tumor and the LI was 3.04. After MAb 15 Fab injection, the percentage of the ID/g of the tumor was 0.31% and the LI was 2.58 at day 1. MAb 15 IgG, F(ab')2, and Fab cleared from the blood early, with a half-life of 33, 16, and 9 hours, respectively. The distributions of MAb 15 and its fragments in the normal organs did not differ from those of the control. Radioimaging with 100 microCi of 131I-labeled MAb 15 and its fragments showed that 42%, 44%, and 32% of the total-body count were localized in the tumor with IgG at day 7, F(ab')2 at day 2, or Fab at day 1, respectively. Because the radioactivity remaining in the tumor with Fab was low, the image was insufficient. Throughout the period, less than 10% of the control IgG and its fragments remained in the tumor. Microautoradiography confirmed the binding of MAb 15 and its fragments to the tumor cells. In this study the F(ab')2 was the best compromise between the slowly cleared IgG and the poorly localized Fab in tumor imaging.

Animals↗